CSIRO researchers have worked with Stanford University scientists to develop a new ultrafast insulin that potentially works four times as fast as current commercial fast-acting insulin formulations. Scientists at CSIRO Manufacturing in Victoria are working on a monomeric insulin that has overcome stability problems usually associated with this molecular structure. Monomeric insulin is usually too ...
Ultrafast insulin in the pipeline thanks to CSIRO
By Michael Woodhead
8 Jul 2020